Presbia PLC IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Presbia PLC, and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Presbia PLC | LENS - NASDAQ |
$11.00-$13.00 |
$10.00 |
$9.25 | 4.2 million | 1/29/2015 |
| Jefferies |
Co-Manager(s): |
| Health Care |
Filing(s):
Filed 2014-03-20
Terms Added 2015-01-15
|
Presbia PLC Quote & Chart - Click for current quote -
LENS
About Presbia PLC (adapted from Presbia PLC prospectus):
They are an ophthalmic device company that has developed and is currently marketing a proprietary optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LENS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved
